Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes.
J Rosenstock,S Sankoh,JF List
Diabetes Obes Metab 2008 5;10(5):376-86

Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes.
RS Rosenson,SL Abby,MR Jones
Atherosclerosis 2008 10;():

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
DM Nathan,JB Buse,MB Davidson,E Ferrannini,RR Holman,R Sherwin,B Zinman
Diabetes Care 2009 1;32(1):193-203

Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes.
B Ahrén,A Schweizer,S Dejager,BE Dunning,PM Nilsson,M Persson,JE Foley
J Clin Endocrinol Metab 2009 1;():

Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates.
FM Sacks,GA Bray,VJ Carey,SR Smith,DH Ryan,SD Anton,K McManus,CM Champagne,LM Bishop,N Laranjo,MS Leboff,JC Rood,L de Jonge,FL Greenway,CM Loria,E Obarzanek,DA Williamson
N Engl J Med 2009 2;360(9):859-73

Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.
DH Zappe,JR Sowers,WA Hsueh,SM Haffner,PC Deedwania,VA Fonseca,L Keeling,DA Sica
J Clin Hypertens (Greenwich) 2008 12;10(12):894-903

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
K Jamerson,MA Weber,GL Bakris,B Dahlöf,B Pitt,V Shi,A Hester,J Gupte,M Gatlin,EJ Velazquez
N Engl J Med 2008 12;359(23):2417-28

10-year follow-up of intensive glucose control in type 2 diabetes.
RR Holman,SK Paul,MA Bethel,DR Matthews,HA Neil
N Engl J Med 2008 10;359(15):1577-89

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein.
PM Ridker,E Danielson,FA Fonseca,J Genest,AM Gotto,JJ Kastelein,W Koenig,P Libby,AJ Lorenzatti,JG Macfadyen,BG Nordestgaard,J Shepherd,JT Willerson,RJ Glynn
N Engl J Med 2008 11;():

Does obesity modify the effect of blood pressure on the risk of cardiovascular disease? A population-based cohort study of more than one million Swedish men.
K Silventoinen,PK Magnusson,M Neovius,J Sundström,GD Batty,P Tynelius,F Rasmussen
Circulation 2008 10;118(16):1637-42

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
HE Bays,RB Goldberg,KE Truitt,MR Jones
Arch Intern Med 2008 10;168(18):1975-83

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
RB Goldberg,VA Fonseca,KE Truitt,MR Jones
Arch Intern Med 2008 7;168(14):1531-40

Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
FJ Zieve,MF Kalin,SL Schwartz,MR Jones,WL Bailey
Clin Ther 2007 1;29(1):74-83